MUSTANG BIO, INC.

Nasdaq:MBIO

Pharmaceutical Preparations·WALTHAM, MA

S. Operating as a partner company of Fortress Biotech, Mustang Bio develops CAR-T immunotherapies and gene therapies for multiple diseases, including hematologic cancers, solid tumors, and X-linked severe combined immunodeficiency (X-SCID).

CEO

Litchman Manuel Md

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/7/25	→
10-Q	Q2 2025	6/30/25	8/8/25	→
10-Q	Q1 2025	3/31/25	5/14/25	→
10-K	FY 2024	12/31/24	3/28/25	→
10-Q	Q3 2024	9/30/24	11/8/24	→
10-Q	Q2 2024	6/30/24	8/13/24	→
↓

Earnings Releases (8-K)

20 shown

Filed	Period
4/29/24	Q1 FY2024	→
3/11/24	Q1 FY2024	→
11/14/23	Q4 FY2023	→
8/14/23	Q3 FY2023	→
5/12/23	Q2 FY2023	→
3/29/23	Q1 FY2023	→
↓

News (8-K)

60 shown

Filed	Type	Description
12/23/25	Vote	Submission of Matters to a Vote of Security Holders	→
7/9/25	Other	Other Events	→
3/5/25	Other	Other Events	→
2/27/25	Acquisition	Completion of Acquisition or Disposition of Assets	→
2/21/25	Vote	Submission of Matters to a Vote of Security Holders	→
2/13/25	Agreement	Entry into a Material Definitive Agreement	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
9/5/25	424B5	424B5	→
4/1/25	424B3	424B3	→
2/27/25	424B3	424B3	→
2/13/25	424B3	424B3	→
2/7/25	424B4	424B4	→
2/5/25	S-1/A	S-1/A	→
↓

Filing History(397 filings)

TypeDateAccessionPeriodSize

SCHEDULE 13D/A

Jan 5, 2026

0001104659-26-000690

—

14.5 KB

Jan 5, 2026

0001429260-26-000002

Jan 2, 2026

5.2 KB

Dec 30, 2025

0001104659-25-125233OWNERSHIP DOCUMENT

Dec 30, 2025

4.9 KB

Dec 30, 2025

0001104659-25-125232OWNERSHIP DOCUMENT

Dec 30, 2025

4.8 KB

Dec 30, 2025

0001104659-25-125227OWNERSHIP DOCUMENT

Dec 30, 2025

5.0 KB

8-K

Dec 23, 2025

0001104659-25-1241898-K

Dec 17, 2025

228.7 KB

DEF 14A

Dec 3, 2025

0001104659-25-118122DEF 14A

Dec 22, 2025

2.4 MB

10-Q

Nov 7, 2025

0001104659-25-10846810-Q

Sep 30, 2025

5.5 MB

SCHEDULE 13D/A

Oct 1, 2025

0001104659-25-095631

—

14.5 KB

Oct 1, 2025

0001429260-25-000004

Sep 29, 2025

5.3 KB

424B5

Sep 5, 2025

0001104659-25-087786424B5

—

14.6 KB

SCHEDULE 13G/A

Aug 12, 2025

0001213900-25-075080

—

11.2 KB

10-Q

Aug 8, 2025

0001558370-25-01092010-Q

Jun 30, 2025

5.5 MB

8-K

Jul 9, 2025

0001104659-25-066520FORM 8-K

Jul 7, 2025

217.2 KB

SCHEDULE 13G/A

May 15, 2025

0001172661-25-002282

—

10.3 KB

10-Q

May 14, 2025

0001558370-25-00773610-Q

Mar 31, 2025

4.7 MB

SCHEDULE 13G/A

May 9, 2025

0001213900-25-041510

—

11.4 KB

Apr 28, 2025

0001104659-25-040237OWNERSHIP DOCUMENT

Apr 24, 2025

5.0 KB

EFFECT

Apr 11, 2025

9999999995-25-001083

—

1.7 KB

POS AM

Apr 4, 2025

0001104659-25-032236POS AM

—

313.0 KB

SCHEDULE 13D/A

Apr 2, 2025

0001104659-25-031261

—

14.4 KB

Apr 2, 2025

0001415889-25-009620

Mar 31, 2025

5.3 KB

POS EX

Apr 1, 2025

0001104659-25-030659POS EX

—

57.4 KB

424B3

Apr 1, 2025

0001104659-25-030657424B3

—

1.7 MB

10-K

Mar 28, 2025

0001558370-25-00391310-K

Dec 31, 2024

10.0 MB

25 filings shown

MUSTANG BIO, INC.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(397 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
12/3/25	DEF 14A	DEF 14A	→
3/3/25	DEF 14C	DEF 14C	→
2/21/25	PRE 14C	PRE 14C	→
1/22/25	DEF 14C	DEF 14C	→
1/10/25	PRE 14C	PRE 14C	→
12/6/24	DEF 14A	DEF 14A	→
↓

Filed	Form	Description
1/5/26	4	4	→
12/30/25	4	OWNERSHIP DOCUMENT	→
12/30/25	4	OWNERSHIP DOCUMENT	→
12/30/25	4	OWNERSHIP DOCUMENT	→
10/1/25	4	4	→
4/28/25	4	OWNERSHIP DOCUMENT	→
↓